Can routine data from prisoners’ files be used to estimate prevalence rates of illicit drug use among prisoners?
The paper examines whether routine data from prisoners’ files is a useful basis to estimate prevalence rates of illicit drug use among prisoners.
Medico-legal files of 190 younger (20–49 years) and 190 older (50–75 years) male prisoners from 13 prisons in Switzerland were analysed. Indications of illicit drug use were extracted based on recorded legal measures, notes from health care professionals, diagnoses related to the use of illicit substances, prescribed medications, other treatment indicators, and results from mandatory drug tests in prison.
Estimated lifetime prevalence of illicit drug use based on those indicators is 50.0% for younger and 24.2% for older prisoners. Current cannabis use is an estimated 10.0% and current cocaine, opioids, or other drug use 4.7% for younger prisoners. Among older prisoners, prevalence of current cannabis use is an estimated 3.2% and of other drug use 0.5%.
The paper concludes that analysing routine data is a reasonable alternative to surveys if prisoners’ files are kept more complete and concise and if data is collected for no other purpose than to benefit prisoners’ health.
KeywordsPrison Health Drug use Routine data Prisoners’ files Switzerland
We are very grateful to the prisons and prisoners who gave us access to their files. The “Agequake” study was funded by the Swiss National Science Foundation (Grant no. CR13I1_135035). BA was supported by the University of Basel “stay on track” measure for highly qualified female postdoctoral researchers in early stages of motherhood. The authors would also like to thank Dr. Violet Handtke for data collection, Angelo Belardi for data management, Dr. Edi Kradolfer for data analyses, and Dorit Barlevy for English revision of the manuscript.
Compliance with ethical standards
Conflict of interest
The authors declare that they have no conflict of interest.
All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. Ethics committees (n = 10) of all involved Swiss cantons approved the study.
Individual consent was not obtained in our study. Prisoners were informed about the study using flyers in different languages that were posted in the prisons and orally by prison health service staff. Those prisoners who did not wish their data to be anonymously extracted, had the possibility to opt-out from the study (i.e. denying access to their medico-legal files) by informing the prison health service. This procedure was approved by ethics committees of all involved cantons.
- Aebi MF, Tiago MM, Burkhardt C (2015) SPACE I—Council of Europe annual penal statistics: prison populations. Survey 2014. Council of Europe, StrasbourgGoogle Scholar
- Eisenbach-Stangl I, Moskalewicz J, Thom B (2010) Two worlds of drug consumption in late modern societies. European Centre, ViennaGoogle Scholar
- European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) (2003) Social exclusion and reintegration. In: European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) (ed) EMCDDA 2003 Annual report on the state of the drugs problem in the European Union and Norway, EMCDDA 2003 selected issue. EMCDDA, Lisbon, pp 65–68Google Scholar
- European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) (2012) Prisons and drugs in Europe: the problem and responses. Publication Office of the European Union, LuxembourgGoogle Scholar
- European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) (2014) European questionnaire on drug use among prisoners (EQDP). http://www.emcdda.europa.eu/system/files/publications/782/Questionnaire_on_Drug_Use_among_Prisoners_%28EQDP%29_479898_1.pdf. Accessed 10 Mar 2017
- Federal Office for Public Health (FOPH) [Bundesamt für Gesundheit (BAG)] (2006) Switzerland’s Drug Policy 2006–2011 [Die Drogenpolitik der Schweiz. Drittes Massnahmepaket des Bundes zur Verminderung der Drogenprobleme (MaPaDro III) 2006–2011]. FOPH, BernGoogle Scholar
- Federal Office for Public Health (FOPH) [Bundesamt für Gesundheit (BAG)] (2012) Communicable diseases and addictions in prison. Vade mecum [Übertragbare Krankheiten und Abhängigkeiten im Gefängnis. Vademekum]. FOPH, BernGoogle Scholar
- Federal Statistical Office (FSO) [Bundesamt für Statistik (BFS)] (2016) Prison sentences and measures: Mean number of detainees of the people over 49 years [Straf- und Massnahmenvollzug: Mittlerer Insassenbestand der über 49-jährigen Personen]. https://www.bfs.admin.ch/bfs/de/home/statistiken/kriminalitaet-strafrecht.assetdetail.303596.html. Accessed 28 Feb 2017
- Gmel G, Kuendig H, Notari L, Gmel C, Flury R (2013) Addiction monitoring in Switzerland—alcohol, tobacco and illegal drug use in Switzerland in 2012 [Monitorage suisse des addictions—Consommation d’alcool, tabac et drogues illégales en Suisse en 2012]. Addiction Suisse, LausanneGoogle Scholar
- Masia M, Achermann C, Richter M, Hostettler U (2007) Survey report: “Analysis of preventive measures and treatment availability for infectious diseases and drug addiction in Swiss correctional facilities” [Auswertungsbericht zur Fragebogenerhebung: „Analyse von Präventionsmassnahmen und Behandlungsangeboten von Infektionskrankheiten und Drogenabhängigkeit in Schweizer Anstalten des Freiheitsentzugs“]. University of Fribourg (Switzerland), FribourgGoogle Scholar
- Moschetti K, Stadelmann P, Wangmo T et al (2015) Disease profiles of detainees in the Canton of Vaud in Switzerland: gender and age differences in substance abuse, mental health and chronic health conditions. BMC Public Health 15:872. doi: 10.1186/s12889-015-2211-6 CrossRefPubMedPubMedCentralGoogle Scholar
- Omolade S (2014) The needs and characteristics of older prisoners: results from the surveying prisoner crime reduction (SPCR) survey. Analytical summary 2014. Ministry of Justice (UK), LondonGoogle Scholar
- Pfefferle M (2015) Substitution in correctional facilites in Switzerland [Substitution in den Haftanstalten der Schweiz]. In: Prison medicine days 2015. Substitution in correctional facilities in Germany and the treatment of diseases related to addictions [Gefängnismedizintage 2015, Substitution im Justizvollzug Deutschlands und die Behandlung von Suchtfolge- und Suchtbegleit-Erkrankungen unter Substitution. 3./4. Dezember 2015] University of Applied Sciences, Frankfurt, pp 64–69Google Scholar
- Stöver H, Weilandt C, Zurhold H, Hartwig C, Thane K (2008) Final report on prevention, treatment, and harm reduction services in prison, on reintegration services on release from prison and methods to monitor/analyse drug use among prisoners. WIAD, BonnGoogle Scholar
- United Nations (1955) Standard minimum rules for the treatment of prisoners. http://www.refworld.org/docid/3ae6b36e8.html. Accessed 28 Feb 2017
- World Health Organisation (WHO) (2013) Good governance for prison health in the 21st century. A policy brief on the organization of prison health. WHO Regional Office for Europe, CopenhagenGoogle Scholar
- World Health Organisation (WHO) (2017) Switzerland: a snapshot of prison health. http://www.euro.who.int/en/health-topics/health-determinants/prisons-and-health/activities/country-work/country-snapshots-interviews-with-national-counterparts/switzerland. Accessed 4 Jan 2017